Compare LCID & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LCID | CRNX |
|---|---|---|
| Founded | 2007 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.1B |
| IPO Year | N/A | 2018 |
| Metric | LCID | CRNX |
|---|---|---|
| Price | $11.87 | $49.28 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 11 |
| Target Price | $24.00 | ★ $71.00 |
| AVG Volume (30 Days) | ★ 8.1M | 1.1M |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,065,533,000.00 | $1,535,000.00 |
| Revenue This Year | $64.89 | $425.31 |
| Revenue Next Year | $82.13 | $943.50 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 45.86 | ★ 47.74 |
| 52 Week Low | $11.46 | $24.10 |
| 52 Week High | $36.40 | $60.25 |
| Indicator | LCID | CRNX |
|---|---|---|
| Relative Strength Index (RSI) | 34.46 | 65.11 |
| Support Level | $12.14 | $46.49 |
| Resistance Level | $13.21 | $50.98 |
| Average True Range (ATR) | 0.71 | 1.95 |
| MACD | 0.10 | 0.35 |
| Stochastic Oscillator | 0.41 | 78.51 |
Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It offers its own geographically distributed retail and service locations and through direct-to-consumer online and retail sales. It also boasts a product roadmap of future vehicle programs and technologies. It focuses on in-house hardware and software innovation, vertical integration, and a clean-sheet approach to engineering and design led to the development of the Lucid Air. The Lucid Air is a luxury sedan that redefines both the luxury car segment and the EV space. Its geographic segments include North America, the Middle East, and Other International.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.